Athersys is a 'very different company' from a year ago, CEO says
February 14, 2023 at 15:40 PM EST
In June 2022, Athersys embarked on a financial and operational restructuring to lower its cost and conserve cash while completing the testing and commercialization of its adult stem-cell therapy.
